Hull, United Kingdom

Amy Brewster

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Wound Care: The Contributions of Inventor Amy Brewster

Introduction: Amy Brewster is an accomplished inventor based in Hull, Great Britain, known for her innovative contributions to the field of wound care. With a total of two patents to her name, her work primarily focuses on developing antimicrobial materials and devices aimed at enhancing wound care applications.

Latest Patents: Brewster's latest patents revolve around advanced antimicrobial or wound care materials. One of her significant inventions includes a composite material featuring a flexible hydrophilic polymer foam or fiber matrix. This matrix comprises two faces that can act as release interfaces, interspersed with a structural matrix framework that defines a network of cells and pores. The integration of a powder charge component, which contains antimicrobial or wound care additives, enhances the functionality of the material. This innovative approach promises substantial improvements in wound healing processes.

Career Highlights: Amy Brewster has established herself as a leader in her field by successfully advancing the development of materials designed to address complex wound care challenges. Her role at Smith & Nephew Pte. Limited enables her to work on cutting-edge products that cater to the needs of healthcare professionals and patients alike.

Collaborations: Brewster collaborates with notable professionals in her field, including Robert Crump and Helene Anne Lecomte. These collaborations foster a dynamic exchange of ideas, further enhancing the effectiveness and reach of her inventions.

Conclusion: Amy Brewster's innovative spirit and dedication to improving healthcare through her inventions underline her significance as an inventor in the field of wound care. With her continuous research and development efforts, she is setting new standards for antimicrobial materials and devices, ultimately aiming to enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…